Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

¹School of Pharmacy, Monash University Malaysia Bandar Sunway, Selangor, Malaysia

²School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia

³School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom

⁴School of Biomedical Sciences and Pharmacy University of Newcastle, Callaghan, Australia

The authors have no conflicts of interest to declare.

All authors contributed equally in the manuscript development. C. S. Kow wrote the first draft of the manuscript. S. S. Hasan revised the first draft of the manuscript and designed the tables.